Tibolone: what does tissue specific activity mean?

被引:29
作者
Palacios, S [1 ]
机构
[1] Inst Palacios Womans Hlth, Madrid 28001, Spain
关键词
tibolone; menopause; tissue specific activity;
D O I
10.1016/S0378-5122(00)00184-5
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Preclinical studies has found that tibolone can display a weak estrogenic. progestational and androgenic activity. The effect produced depends mainly on the target tissue involved. Clinical data indicate that tibolone produces the hormonal effects needed to treat climacteric symptoms and to prevent long-term effects of the menopause without stimulating breast and endometrial tissues. This clinical profile would be produced by the tissue specific activity of tibolone and its main metabolites. Tibolone's tissue specific activity may be explained by the interplay of several mechanisms, such as the metabolic conversion of tibolone to compounds with different biological activity. the classical interaction with the steroid receptor and the specific local metabolism. within the target tissue. Therefore. the tissue response and thus the clinical effect produced by tibolone in a given tissue seem to depend on the predominating mechanisms and interactions present in that tissue. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:159 / 165
页数:7
相关论文
共 50 条
[21]   Long term influence of different postmenopausal hormone replacement regimens on serum lipids and lipoprotein(a): A randomised study [J].
Hanggi, W ;
Lippuner, K ;
Riesen, W ;
Jaeger, P ;
Birkhauser, MH .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1997, 104 (06) :708-717
[22]  
HERSHBERGER LG, 1953, P SOC EXP BIOL MED, V83, P175
[23]   Hormone replacement therapy and breast cancer [J].
Kenemans, P ;
Stampfer, M .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1996, 67 (01) :1-4
[24]   LONG-TERM EFFECTS OF ORG-OD-14 ON LIPID-METABOLISM IN POSTMENOPAUSAL WOMEN [J].
KLOOSTERBOER, HJ ;
BENEDEKJASZMANN, LJ ;
KICOVIC, PM .
MATURITAS, 1990, 12 (01) :37-42
[25]   EFFECTS OF PROGESTAGENS AND ORG-OD14 IN IN-VITRO AND IN-VIVO TUMOR-MODELS [J].
KLOOSTERBOER, HJ ;
SCHOONEN, WGEJ ;
DECKERS, GH ;
KLIJN, JGM .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1994, 49 (4-6) :311-318
[26]  
KLOOSTERBOER HJ, 1997, GYNECOL ENDOCRINOL, V11, P63
[27]  
KLOOSTERBOER HJ, 1997, ACTA OBSTET GYN S167, V76, P59
[28]   ESTRADIOL STIMULATES C-MYC PROTOONCOGENE EXPRESSION IN NORMAL HUMAN BREAST EPITHELIAL-CELLS IN CULTURE [J].
LEYGUE, E ;
GOLWINKLER, R ;
GOMPEL, A ;
LOUISSYLVESTRE, C ;
SOQUET, L ;
STAUB, S ;
KUTTENN, F ;
MAUVAISJARVIS, P .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1995, 52 (04) :299-305
[29]  
LIPPUNER K, 1996 WORLD C OST ASM
[30]   INVITRO EVALUATION OF ESTROGENIC, ESTROGEN ANTAGONISTIC AND PROGESTAGENIC EFFECTS OF A STEROIDAL DRUG (ORG OD-14) AND ITS METABOLITES ON HUMAN ENDOMETRIUM [J].
MARKIEWICZ, L ;
GURPIDE, E .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1990, 35 (05) :535-541